Nothing Special   »   [go: up one dir, main page]

DK2185937T4 - Fremgangsmåde til at bestemme sepsis hos mennesker - Google Patents

Fremgangsmåde til at bestemme sepsis hos mennesker

Info

Publication number
DK2185937T4
DK2185937T4 DK08801791.8T DK08801791T DK2185937T4 DK 2185937 T4 DK2185937 T4 DK 2185937T4 DK 08801791 T DK08801791 T DK 08801791T DK 2185937 T4 DK2185937 T4 DK 2185937T4
Authority
DK
Denmark
Prior art keywords
humans
sepsis
procedure
psp
serum
Prior art date
Application number
DK08801791.8T
Other languages
English (en)
Other versions
DK2185937T3 (da
Inventor
Rolf Graf
Daniel Bimmler
Marius Keel
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40040164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2185937(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Zuerich filed Critical Univ Zuerich
Publication of DK2185937T3 publication Critical patent/DK2185937T3/da
Application granted granted Critical
Publication of DK2185937T4 publication Critical patent/DK2185937T4/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/474—Pancreatic thread protein; Reg protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK08801791.8T 2007-09-07 2008-09-02 Fremgangsmåde til at bestemme sepsis hos mennesker DK2185937T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07017539 2007-09-07
PCT/EP2008/007158 WO2009030456A1 (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans

Publications (2)

Publication Number Publication Date
DK2185937T3 DK2185937T3 (da) 2011-09-12
DK2185937T4 true DK2185937T4 (da) 2014-10-20

Family

ID=40040164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08801791.8T DK2185937T4 (da) 2007-09-07 2008-09-02 Fremgangsmåde til at bestemme sepsis hos mennesker

Country Status (13)

Country Link
US (2) US8435755B2 (da)
EP (1) EP2185937B2 (da)
JP (1) JP5048838B2 (da)
CN (1) CN101796418B (da)
AT (1) ATE514950T1 (da)
AU (1) AU2008295046B2 (da)
CA (1) CA2696319C (da)
DK (1) DK2185937T4 (da)
ES (1) ES2368877T5 (da)
NZ (1) NZ583474A (da)
PL (1) PL2185937T5 (da)
PT (1) PT2185937E (da)
WO (1) WO2009030456A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151783A1 (en) * 2010-05-31 2011-12-08 University Hospital Of Basel Method for assaying lower respiratory tract infection or inflammation
PT2612152T (pt) 2010-08-31 2020-09-03 Univ Otto Von Guericke Magdeburg Método para diagnosticar peritonite infeciosa e prever a sua gravidade e resultados em humanos
US20130004968A1 (en) * 2010-09-22 2013-01-03 Robert Webber Sepsis blood biomarker system
WO2014009480A1 (en) 2012-07-12 2014-01-16 Universität Zürich Method for assaying sepsis and outcome in humans by detection of psp/reg
US20140120174A1 (en) * 2012-10-30 2014-05-01 Lascco, Sa Methods of prognosis and diagnosis of sepsis
WO2014117165A1 (en) * 2013-01-28 2014-07-31 Vanderbilt University Method for differentiating sepsis and systemic inflammatory response syndrome (sirs)
EP2813852A3 (en) 2013-06-11 2015-03-25 University Of Zurich Method for detecting the development of an infection in humans
CN106367488A (zh) * 2016-08-29 2017-02-01 北京泱深生物信息技术有限公司 Letmd1在脓毒症诊断中的应用
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
CN111094987B (zh) 2017-09-13 2023-10-31 B.R.A.H.M.S有限公司 作为异常血小板水平的标志物的肾上腺髓质素原
CN108181472B (zh) * 2018-03-05 2020-07-21 吉林大学 昆虫细胞表达psp为校准品的检测psp试剂盒
EP3578989A1 (en) * 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2006332C (en) 1988-12-21 2003-04-08 Suzanne De La Monte Method of detecting neurological disease or dysfunction
GB9613629D0 (en) 1996-06-28 1996-08-28 Univ Leeds Reg gene expression in cancer tissue
EP1318403B1 (de) * 2001-12-04 2004-07-28 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Sepsis unter Bestimmung von S100B
EP1318405B1 (de) * 2001-12-04 2004-11-17 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
DE50105971D1 (de) * 2001-12-04 2005-05-25 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
ATE272215T1 (de) * 2001-12-04 2004-08-15 Brahms Ag Verfahren zur diagnose von sepsis unter bestimmung von ca 19-9
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
JP2004194534A (ja) * 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
US20040265230A1 (en) * 2003-01-06 2004-12-30 Martinez Robert Vincent Compositions and methods for diagnosing and treating colon cancers
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US20070224638A1 (en) * 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
WO2011151783A1 (en) * 2010-05-31 2011-12-08 University Hospital Of Basel Method for assaying lower respiratory tract infection or inflammation

Also Published As

Publication number Publication date
PL2185937T3 (pl) 2012-02-29
NZ583474A (en) 2011-07-29
CN101796418A (zh) 2010-08-04
EP2185937B2 (en) 2014-07-16
CA2696319A1 (en) 2009-03-12
US20100222223A1 (en) 2010-09-02
AU2008295046A1 (en) 2009-03-12
EP2185937B1 (en) 2011-06-29
US8435755B2 (en) 2013-05-07
PL2185937T5 (pl) 2014-12-31
US9857381B2 (en) 2018-01-02
ATE514950T1 (de) 2011-07-15
JP2010538282A (ja) 2010-12-09
DK2185937T3 (da) 2011-09-12
US20130203612A1 (en) 2013-08-08
PT2185937E (pt) 2011-09-06
ES2368877T5 (es) 2014-10-20
ES2368877T3 (es) 2011-11-23
WO2009030456A1 (en) 2009-03-12
AU2008295046B2 (en) 2013-08-01
EP2185937A1 (en) 2010-05-19
CN101796418B (zh) 2013-05-01
CA2696319C (en) 2021-02-02
JP5048838B2 (ja) 2012-10-17

Similar Documents

Publication Publication Date Title
DK2185937T4 (da) Fremgangsmåde til at bestemme sepsis hos mennesker
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
EA200970180A1 (ru) Способ предсказания агрегации белков и конструирования ингибиторов агрегации
BR112014006741A2 (pt) método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
MA34263B1 (fr) Marqueurs de prédiction utiles dans traitement du syndrome de l'x fragile (fxs)
DK1625163T3 (da) Fremgangsmåde til at påvise proBNP med en monoklonal antistofbinding til aminosyrerne 38-43
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
WO2010021822A3 (en) Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
DK2005185T3 (da) Fremgangsmåde til identifikation af polypeptidtargets
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
WO2006124526A3 (en) Method for assessing the effectiveness of a treatment regimen by determining zonulin
WO2008012362A3 (en) New protein isoforms and uses thereof
WO2010061283A3 (en) Biomarkers for diagnosing and detecting the progression of neurodegenerative disorders, in particular of amyotrophic lateral sclerosis
ATE489623T1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
DE602007012836D1 (de) Cd86- und cd80-rezeptorkonkurrenztests
DK1907854T3 (da) Monoklonale antistoffer, hybridomcellelinjer, fremgangsmåder og kits til detektion af phytase
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
BRPI0817393A2 (pt) Anticorpo monoclonal, polipetídeo solúvel isolado, método de inibição do progresso de tumores, método de inibição de emt em células e método de determinação se um tumor reagirá a um antagonista de b2 ou um antagonista de notch
MX2009008525A (es) La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение